Dingdang Health repurchases 119,500 shares; treasury stock climbs to 1.13 million

Bulletin Express08-26

Dingdang Health Technology Group Ltd. filed a Next Day Disclosure Return on 26 August 2026, confirming an on-market buyback executed the same day.

The company repurchased 119,500 ordinary shares on the Hong Kong Stock Exchange at prices ranging between HK$0.81 and HK$0.82, equivalent to a volume-weighted average of HK$0.8177 per share. The total consideration was HK$0.10 million.

Following the transaction: • Issued shares (excluding treasury shares) fell to 1.24 billion. • Treasury shares increased to 1.13 million, representing roughly 0.09% of outstanding shares. • Total issued share capital remained unchanged at 1.24 billion shares, as the repurchased stock is held in treasury.

The buyback utilised part of the general mandate approved on 23 June 2026, which authorises repurchases of up to 124.32 million shares. To date, 3.99 million shares—about 0.32% of the company’s issued shares on the mandate date—have been repurchased, leaving approximately 120.33 million shares still available under the authorisation.

In accordance with Hong Kong listing rules, Dingdang Health is subject to a 30-day moratorium on issuing new shares or disposing of treasury shares, effective until 25 September 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1199662325?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-26 19:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1199662325","market":"us","top_or_hot":-1,"title":"Dingdang Health repurchases 119,500 shares; treasury stock climbs to 1.13 million","media":"Bulletin Express","content":"<p>Dingdang Health Technology Group Ltd. filed a Next Day Disclosure Return on 26 August 2026, confirming an on-market buyback executed the same day.</p>\n<p>The company repurchased 119,500 ordinary shares on the Hong Kong Stock Exchange at prices ranging between HK$0.81 and HK$0.82, equivalent to a volume-weighted average of HK$0.8177 per share. The total consideration was HK$0.10 million.</p>\n<p>Following the transaction:\n• Issued shares (excluding treasury shares) fell to 1.24 billion.  \n• Treasury shares increased to 1.13 million, representing roughly 0.09% of outstanding shares.  \n• Total issued share capital remained unchanged at 1.24 billion shares, as the repurchased stock is held in treasury.</p>\n<p>The buyback utilised part of the general mandate approved on 23 June 2026, which authorises repurchases of up to 124.32 million shares. To date, 3.99 million shares—about 0.32% of the company’s issued shares on the mandate date—have been repurchased, leaving approximately 120.33 million shares still available under the authorisation.</p>\n<p>In accordance with Hong Kong listing rules, Dingdang Health is subject to a 30-day moratorium on issuing new shares or disposing of treasury shares, effective until 25 September 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health repurchases 119,500 shares; treasury stock climbs to 1.13 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health repurchases 119,500 shares; treasury stock climbs to 1.13 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-26 19:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dingdang Health Technology Group Ltd. filed a Next Day Disclosure Return on 26 August 2026, confirming an on-market buyback executed the same day.</p>\n<p>The company repurchased 119,500 ordinary shares on the Hong Kong Stock Exchange at prices ranging between HK$0.81 and HK$0.82, equivalent to a volume-weighted average of HK$0.8177 per share. The total consideration was HK$0.10 million.</p>\n<p>Following the transaction:\n• Issued shares (excluding treasury shares) fell to 1.24 billion.  \n• Treasury shares increased to 1.13 million, representing roughly 0.09% of outstanding shares.  \n• Total issued share capital remained unchanged at 1.24 billion shares, as the repurchased stock is held in treasury.</p>\n<p>The buyback utilised part of the general mandate approved on 23 June 2026, which authorises repurchases of up to 124.32 million shares. To date, 3.99 million shares—about 0.32% of the company’s issued shares on the mandate date—have been repurchased, leaving approximately 120.33 million shares still available under the authorisation.</p>\n<p>In accordance with Hong Kong listing rules, Dingdang Health is subject to a 30-day moratorium on issuing new shares or disposing of treasury shares, effective until 25 September 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1199662325","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1199662325","pubTimestamp":1787742117,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Dingdang Health Technology Group Ltd. filed a Next Day Disclosure Return on 26 August 2026, confirming an on-market buyback executed the same day. The company repurchased 119,500 ordinary shares on...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康回购11.95万股；美国国库股攀升至113万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"Dingdang Health Technology Group Ltd. filed a Next Day Disclosure Return on 26 August 2026, confirming an on-market buyback executed the same day.\nThe company repurchased 119,500 ordinary shares on the Hong Kong Stock Exchange at prices ranging between HK$0.81 and HK$0.82, equivalent to a volume-weighted average of HK$0.8177 per share. The total consideration was HK$0.10 million.\nFollowing the transaction:\n• Issued shares (excluding treasury shares) fell to 1.24 billion.  \n• Treasury shares increased to 1.13 million, representing roughly 0.09% of outstanding shares.  \n• Total issued share capital remained unchanged at 1.24 billion shares, as the repurchased stock is held in treasury.\nThe buyback utilised part of the general mandate approved on 23 June 2026, which authorises repurchases of up to 124.32 million shares. To date, 3.99 million shares—about 0.32% of the company’s issued shares on the mandate date—have been repurchased, leaving approximately 120.33 million shares still available under the authorisation.\nIn accordance with Hong Kong listing rules, Dingdang Health is subject to a 30-day moratorium on issuing new shares or disposing of treasury shares, effective until 25 September 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1199662325","isCrawlerRequest":true}